What does a full-body MRI find in people with no symptoms? What the studies show
The essentials
- Across 12 studies of 5,373 adults with no known disease, about 1 in 3 (32.1%) had a critical or indeterminate finding.[1]
- About 1 in 64 adults with no symptoms (1.57%) had a confirmed cancer, according to 10 studies of 9,024 people.[2]
- In a German study, disclosing findings to people who had the MRI was associated with 11.6% higher outpatient spending over 24 months.[3]
- No study has measured whether people who get scanned live longer than those who do not.[4]
Why every study gives different numbers
If you look up how many people have "something" on a full-body MRI, you will find very different figures. A systematic review of 12 studies with 5,373 adults with no known disease, syndrome or mutation found enormous variation between studies (I² of 95.6 to 99.1%), because protocols differ.[1] The clearest factor was what was scanned: studies that included blood vessels or the colon reported critical or indeterminate findings in 49.7% of participants, versus 23.0% in those that did not.[1]
The main numbers
These are the largest studies and reviews we found on adults with no symptoms, with what each reported:
| Study | Who | What was found |
|---|---|---|
| Kwee review, 2019[1] | 12 studies, 5,373 adults with no known disease | Critical or indeterminate findings: 32.1% (critical 13.4%; indeterminate 13.9%) |
| SHIP, Germany (Hegenscheid, 2013)[5] | 2,500 adults from the general population | Potentially relevant findings in about 36%; disclosed to about 31.5% |
| SHIP, costs (Schmidt, 2022)[3] | 2,969 people with MRI, out of 5,019 | Findings disclosed to 948 people (32%); 1,366 potentially relevant findings, mostly masses or lesions |
| Hu cohort, 2024[6] | 2,064 adults with no symptoms (median age 55) | Confirmed cancer in 24 people (1.2%, about 1 in 86) |
| da Fonseca meta-analysis, 2026[2] | 10 studies, 9,024 people | Confirmed cancer: 1.57% (95% CI 1.22 to 2.03%), about 1 in 64 |
A review written for Canadian family physicians summarizes the same literature this way: 94% of people had at least one finding (about 4.5 per person in studies that reported totals); 30% needed additional tests in one review and 12% in another, and between 1.1% and 1.6% had a confirmed cancer. The most common were prostate, kidney and lung.[4]
A US center that reported its first 18 months (about 160 patients) described something similar: about 90% had some finding, most needing no follow-up; around 30% had findings that were not worrying in themselves but needed follow-up, and about 1% had findings that were malignant or suspected to be malignant.[7]
When there is a cancer: the question of overdiagnosis
When a cancer is confirmed, another question remains: would it ever have caused harm? That is the idea of overdiagnosis, which means detecting tumors that might never have caused symptoms or shortened life. So finding more cancers does not necessarily mean fewer people die.[7] And that is exactly the data that does not exist: the Tools for Practice review notes that there are no mortality data and that its authors could not calculate sensitivity or specificity, because it is unknown how many people with a negative scan later developed cancer.[4]
How results are graded: ONCO-RADS
ONCO-RADS grades a full-body MRI in five categories, from 1 (normal) to 5 (malignant finding highly likely).[8][6] In the cohort of Hu and colleagues (2,064 adults with no symptoms), the share of people with confirmed cancer rose with the category: 0.1% in category 2, 5.4% in category 3, 42.9% in category 4 and 75% in category 5. Only 43 participants (2.1%) were in category 4 or higher.[6]
Two lessons: the vast majority of results (97.9%) were category 3 or lower, and a low category was associated with very little cancer risk, while a high category justifies follow-up. This is a retrospective study, and its authors conclude that the categories correlate with cancer risk, not that they guarantee an outcome.[6]
The cost of follow-up
In the SHIP study, 2,969 people had a full-body MRI and the other 2,050 served as a comparison. Over the next 24 months, average outpatient spending was €2,839 for those who had the MRI versus €2,547 for those who did not: €295 more per person (11.6%; 95% CI 5.2 to 17.9%). The increase persisted over time and was driven mainly by more imaging and specialist visits.[3]
Besides money, the RSNA News report lists anxiety, appointments and additional tests as burdens of follow-up, and sometimes biopsies for findings that turn out to be benign.[7]
What medical societies recommend
The American College of Radiology (2023) does not consider the evidence sufficient to support whole-body screening in people with no symptoms, risk factors or family history, and warns that it generates many nonspecific findings that lead to more tests and expense.[9] The Royal Australian and New Zealand College of Radiologists also does not recommend it in people with no symptoms, no previous cancer and no cancer predisposition.[10] The Tools for Practice review concludes that it should not be encouraged,[4] and the 2026 meta-analysis sees potential as an opportunistic tool, but limited today by the low detection rate, unstandardized protocols and lack of long-term data.[2]
For the picture of when there is evidence (Li-Fraumeni syndrome, myeloma), read the first part of this series: Full-body MRI: what it can detect and when the evidence says it helps.
If you are still considering one: questions to ask first
- Which regions does the protocol include? Including blood vessels and the colon increases the number of findings.[1]
- How are results reported? Ask whether a standardized system such as ONCO-RADS is used.
- Who coordinates follow-up if an indeterminate finding turns up, and who pays for the additional tests?
- Do I have symptoms or a family history that would justify a targeted study or genetic counseling instead of a whole-body one?
- Am I up to date with the screening tests that do have evidence and that my doctor recommends for my age, sex and history?
This does not replace a consultation with your doctor.
At Vilab
If you decide to explore full-body MRI or ultrasound, the imaging page lets you compare both studies and request a quote on WhatsApp. Duration, preparation and final scope are set by the doctor for your case. If what you want is a preventive check-up with lab tests and a consultation to interpret your results, see the packages and pricing.
Frequently asked questions
Is it normal for a full-body MRI to find something?
Yes. In reviews of adults with no symptoms, the vast majority have at least one finding (94% in one review), but the vast majority of those findings are not cancer: between 1.1% and 1.6% of people (roughly 1 in 90 to 1 in 60) had a confirmed cancer.[4]
What is an incidental finding?
It is something seen on the exam that is unrelated to the reason it was done. It can be benign, indeterminate or, less often, important.
Does a normal result guarantee I do not have cancer?
Not necessarily. None of the studies in Kwee's review verified normal results beyond five years, and one reported a 2.0% false-negative proportion.[1] A normal result does not guarantee there is no cancer.
Does it replace mammography, colonoscopy or other screening tests?
The sources we reviewed give no evidence that it can replace screening tests that already have support. Ask your doctor which ones apply to you based on your age, sex and history.
References
- Kwee RM, Kwee TC. Whole-body MRI for preventive health screening: a systematic review of the literature. J Magn Reson Imaging. 2019;50(5):1489-1503. Open the source
- da Fonseca JM, Trennepohl T, Pinheiro LG, et al. Whole-body MRI for opportunistic cancer detection in asymptomatic individuals: a systematic review and meta-analysis. Eur Radiol. 2026;36(3):1813-1823. Open the source
- Schmidt CO, Sierocinski E, Baumeister S, Hegenscheid K, Völzke H, Chenot JF. Effects of whole-body MRI on outpatient health service costs: a general-population prospective cohort study in Mecklenburg-Vorpommern, Germany. BMJ Open. 2022;12(1):e056572. Open the source
- Maplethorpe E, Low G, Kolber MR. Whole-body MRI for cancer screening: many findings, little benefit. Tools for Practice no. 410. College of Family Physicians of Canada. Open the source
- Hegenscheid K, Seipel R, Schmidt CO, et al. Potentially relevant incidental findings on research whole-body MRI in the general adult population: frequencies and management. Eur Radiol. 2013;23(3):816-826. Open the source
- Hu YS, Wu CA, Lin DC, et al. Applying ONCO-RADS to whole-body MRI cancer screening in a retrospective cohort of asymptomatic individuals. Cancer Imaging. 2024;24(1). Open the source
- Henderson M. Whole-body MRI expands, leaving patients weighing risks. RSNA News. July 1, 2026. Open the source
- Petralia G, Koh DM, Attariwala R, et al. Oncologically Relevant Findings Reporting and Data System (ONCO-RADS): guidelines for the acquisition, interpretation, and reporting of whole-body MRI for cancer screening. Radiology. 2021;299(3). Open the source
- American College of Radiology. ACR statement on screening total body MRI. April 17, 2023. Open the source
- Royal Australian and New Zealand College of Radiologists (RANZCR). Whole body MRI screening in low-risk patients: position statement (updated 20 May 2026). Open the source
Keep reading
Full-body MRI: what it can detect and when the evidence says it helps
We reviewed the published studies and guidelines: which risk groups have evidence for full-body MRI, what findings were documented and where its limits are.